MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CORREIA, M. A.
Right arrow Articles by MANNERING, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CORREIA, M. A.
Right arrow Articles by MANNERING, G. J.

Molecular Pharmacology, Vol 9, 455-469, Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics

Reduced Diphosphopyridine Nucleotide Synergism of the Reduced Triphosphopyridine Nucleotide-Dependent Mixed-Function Oxidase System of Hepatic Microsomes

I. Effects of Activation and Inhibition of the Fatty Acyl Coenzyme A Desaturation System

MARIA ALMIRA CORREIA 1 and G. J. MANNERING 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

Time first of the 2 electrons required for the N-demethylation of ethylmorphine by the microsomal mixed-function oxidase system of liver is thought to be donated by TPNH, whereas the second has been postulated to be derivable from either TPNH or DPNH and transported to the cytochrome P-450 system via cytochrome b5. DPNH is believed to support a larger pool of second electrons at cytochrome b5 than can be supplied by TPNH, and this would explain the synergistic effect of DPNH on TPNH-dependent mixed-function oxidase reactions. This concept was strengthened by the current studies, which altered the pool of second electrons at cytochrome b5 by manipulating the shunt of electrons from cytochrome b5 to the microsomal fatty acyl-CoA desaturation system. When the activity of this shunt was inhibited with cyanide, DPNH synergism of ethylmorphine N-demethylation was increased from 30% (no cyanide) to 90% (0.1 or 0.5 mM cyanide). Cyanide had little or no effect on N-demethylation when TPNH was the sole source of electrons. When the activity of the desaturation system was stimulated by the addition of stearoyl-CoA, a natural substrate for the system, rates of N-demethylation declined when TPNH was the sole donor of electrons and when both TPNH and DPNH were present. Cyanide reversed the inhibitory effect of stearoyl-CoA. These results are interpreted to mean that second electrons, which are normally transported from DPNH through cytochrome b5 to the cytochrome P-450 system, are dissipated in large part via cyanide-sensitive systems engaged in the oxidation of endogenous substrates; cyanide largely prevents this dissipation of second electrons, more of the electron pool at cytochrome b5 is made available to the cytochrome P-450 system, and DPNH synergism is enhanced. Cyanide is without effect on the cytochrome P-450 system when TPNH is the sole source of electrons, because the steady-state concentration of reduced cytochrome b5 that can be maintained by TPNH is below the level where a serious loss of electrons to endogenous systems via cytochrome b5 can occur. Stearoyl-CoA increases the dissipation of electrons by serving as a substrate for the cyanide-sensitive desaturation system. It is postulated that stearoyl-CoA inhibits ethylmorphine N-demethylation because the desaturation system and the mixed-function oxidase system compete for electrons supplied by an unidentified electron transfer component, which accepts electrons from either DPNH or TPNH via cytochrome b5. These concepts were reinforced by studies in which rates of DPNH utilization were correlated with rates of ethylmorphine N-demethylation.

Note:
ACKNOWLEDGMENT The authors gratefully acknowledge the able technical assistance of Miss Virginia Kickertz.

Submitted on December 14, 1972




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
C. A. Lee, P. T. Manyike, K. E. Thummel, S. D. Nelson, and J. T. Slattery
Mechanism of Cytochrome P450 Activation by Caffeine and 7,8-Benzoflavone in Rat Liver Microsomes
Drug Metab. Dispos., October 1, 1997; 25(10): 1150 - 1156.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics